Senior Director, Lung Cancer, Solid Tumor Business Unit

About the role

Johnson & Johnson's Innovative Medicine division is looking for a Senior Director for its Lung Cancer, Solid Tumor Business Unit in Chiyoda, Tokyo. The role leads the commercial strategy for the Lung Cancer portfolio and the Rybrevant brand, with full P&L responsibility.

Key responsibilities

• Develop and implement the business strategy for the Lung Cancer portfolio and Rybrevant brand, with short- and long-term objectives.
• Oversee and lead all marketing and sales plans within policy, guidelines and the Business Unit budget.
• Deliver the agreed forecast budget and business plan, including top and bottom-line metrics, with full P&L responsibility.
• Inspire and lead the commercial team to deliver outcomes and maximize their potential.
• Lead marketing and sales activities so that short- and long-range sales volumes and projects are achieved.
• Develop and implement short- and long-range sales and marketing plans, and oversee the development of sales and marketing processes.
• Build strong partnerships with co-promotion partner companies.
• Formulate marketing objectives, policies, the sales organization structure and sales and marketing plans to achieve maximum sales and profit.
• Provide input on product development that anticipates and serves customer needs, and identify new markets and applications to drive volume growth.
• Coach, mentor and appraise subordinates and others' performance and development.

Required profile

• Bachelor's degree or equivalent; MBA or Master's degree preferred.
• 10+ years of related commercial experience.
• At least 5 years of marketing experience in the pharma industry and people management experience.
• In-depth knowledge of the Japan healthcare environment and systems.
• Pharma sales experience is an advantage; preferably oncology experience.
• An excellent track record in past positions.

Required skills

• Commercial management and strategic sales planning
• Negotiation and client management
• Pricing strategies and operational excellence